Foley Partner Paul Broude authored an article titled “The IPO Window Is Opening” in the March 2010 issue of MX: Medtech Executive. Broude examines the reasons for a device company to consider an initial public offering for its growth plans, stating that 2010 may bring the promise of IPOs for medical device companies to fund clinical trials, regulatory approvals, and the protection of the company’s intellectual property. He adds that going public enables some medical device and life science companies to continue growing while creating an exit vehicle for management and other shareholders.
Author(s)
Related Insights
August 11, 2025
Labor & Employment Law Perspectives
Washington State Expands Paid Sick Leave Law To Include Coverage for Immigration Proceedings and Hate Crime Victims
As we have previously discussed, state paid sick leave laws continue expanding. In 2025, states which previously had no sick leave…
August 11, 2025
Labor & Employment Law Perspectives
2025 Changes in Texas Employment Laws That Employers Must Comply With
As we pass the halfway point of 2025, there has already been a flurry of legislative changes and court decisions that have changed the…
August 8, 2025
Foley Ignite
The Rise of "Acquihiring" in a Post-Layoff Tech Sector
As a practicing M&A attorney representing both strategic acquirers and venture-backed targets, I have had a front row seat to the…